欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
HU/H/0771/002
药品名称
Pazopanib Teva 400 mg filmtabletta
活性成分
Pazopanib hydrochloride 400.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva B.V. Swensweg 5 Haarlem 2031 GA Netherlands
参考成员国 - 产品名称
Hungary (HU)
互认成员国 - 产品名称
Netherlands (NL)
Ireland (IE)
France (FR)
Portugal (PT)
Italy (IT)
Latvia (LV)
Greece (GR)
Lithuania (LT)
Pazopanib Teva 400 mg plėvele dengtos tabletės
Slovenia (SI)
Estonia (EE)
Bulgaria (BG)
Pazopanib Teva
Romania (RO)
PAZOPANIB TEVA 400 mg, comprimate filmate
Slovakia (SK)
Croatia (HR)
许可日期
2021/12/07
最近更新日期
2024/11/19
药物ATC编码
L01XE11 pazopanib
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase